Xilio Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 12/05/2026 | Sep 2025Filed 13/11/2025 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 12/05/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 14/08/2025 | Mar 2024Filed 08/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $19 | $13 | $19 | $8.1 | $2.9 | $2.3 | $2.4 | — | |
| −$6.4 | −$9.5 | −$16 | −$16 | −$13 | −$14 | −$14 | −$17 | |
| −$0.33 | −$0.58 | −$0.11 | −$2.30 | −$2.49 | −$0.22 | −$0.24 | −$0.62 | |
| 19 | 16 | 144 | 6.9 | 5.3 | 63 | 58 | 28 |
Trend